Results 141 to 150 of about 14,109,241 (348)

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Solution and quality robust project scheduling: a methodological framework. [PDF]

The vast majority of the research efforts in project scheduling over the past several years has concentrated on the development of exact and suboptimal procedures for the generation of a baseline schedule assuming complete information and a deterministic
Herroelen, Willy, Leus, Roel
core  

Pfair scheduling of generalized pinwheel task systems [PDF]

, 2011
[[abstract]]The scheduling of generalized pinwheel task systems is considered. It is shown that pinwheel scheduling is closely related to the fair scheduling of periodic task systems. This relationship is exploited to obtain new scheduling algorithms for
Baruah, S. K.;Lin, Shun-Shii
core  

A Combined Algorithm Using Both the MINLP Model and Approximated MILP Model for PVC Production Scheduling. [PDF]

ACS Omega, 2022
Su J, Wang Y, Gao X.
europepmc   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Integrating nurse and surgery scheduling. [PDF]

Scheduling; Surgery scheduling; International; Theory; Applications; Euro; Researchers;
Belien, Jeroen, Demeulemeester, Erik
core  

Algorithm for Solving Distributed Workshop Scheduling Model Based on Order Constraints and Assembly Constraints

IEEE Access
With the transformation of manufacturing towards intelligence and flexibility, the workshop scheduling problem, as a typical combinatorial optimization problem, is facing increasingly complex constraints and requirements. In the actual production process,
Tingting Qu
doaj   +1 more source

Workforce planning and production scheduling in a reconfigurable manufacturing system facing the COVID-19 pandemic. [PDF]

J Manuf Syst, 2022
Vahedi-Nouri B, Tavakkoli-Moghaddam R, Hanzálek Z, Dolgui A.   +3 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source